Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

<i>In Vivo</i> Activity of Antimicrobial Peptoid Oligomers against HSV-1 in a Mouse Model of Herpes Labialis.

ACS infectious diseases·2026
Same author

MDM2 suppresses c-Myc synthesis by binding to the 5' mRNA translation regulatory sequence.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

YAP/TAZ inhibition refines TGF-β signaling to prevent laryngeal fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Quantitative holographic agglutination assay for immunoglobulin A.

Biomedical optics express·2026
Same author

Structural and Positional Effects of Peptoid Residues on Triple Helix Stability.

Biomacromolecules·2026
Same author

Native Chemical Ligation of Peptoid Oligomers.

Biochemistry·2026

Video Experimental Relacionado

Updated: May 23, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Conjugados peptidomiméticos multivalentes: una plataforma versátil para modular la actividad del receptor de

Paul M Levine1, Keren Imberg, Michael J Garabedian

  • 1Department of Chemistry, New York University, New York, New York 10003, USA.

Journal of the American Chemical Society
|April 19, 2012
PubMed
Resumen

Los investigadores desarrollaron nuevos conjugados peptidomiméticos multivalentes para modular la actividad del receptor de andrógenos (AR). Estos conjugados muestran potentes efectos antiproliferativos en modelos de cáncer de próstata resistentes a la terapia, ofreciendo nuevas estrategias terapéuticas.

Más Videos Relacionados

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
10:36

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Videos de Experimentos Relacionados

Last Updated: May 23, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
10:36

In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues

Published on: March 21, 2017

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Área de la Ciencia:

  • Química Medicinal La Química Medicinal es un campo de estudio de la química medicinal.
  • Biología Molecular Biología Molecular
  • Oncología Oncología.

Sus antecedentes:

  • El receptor de andrógenos (AR) es un objetivo clave en la terapia del cáncer de próstata.
  • El cáncer de próstata resistente a la terapia sigue siendo un desafío clínico significativo.
  • El desarrollo de nuevos moduladores de AR es crucial para mejorar los resultados del tratamiento.

Objetivo del estudio:

  • Diseñar y sintetizar nuevos conjugados peptidomiméticos multivalentes dirigidos al receptor de andrógenos.
  • Para evaluar la actividad anti-proliferativa de estos conjugados en las células de cáncer de próstata.
  • Para aclarar el mecanismo de acción de los desarrollados moduladores AR.

Principales métodos:

  • Conjugación de los ligandos bioactivos de la etisterona con los oligómeros peptoides específicos de la secuencia.
  • Evaluación de la activación transcripcional mediada por AR.
  • Evaluación de la actividad antiproliferativa en las células LNCaP-abl (un modelo para el cáncer de próstata resistente a la terapia).
  • Ensayos de unión de ligandos in vitro para determinar la inhibición competitiva o no competitiva.

Principales resultados:

  • Se sintetizó con éxito una familia de conjugados peptidomiméticos multivalentes dirigidos al receptor de andrógenos.
  • Ciertos conjugados demostraron una mayor activación transcripcional mediada por AR.
  • Un conjugado lineal exhibió una inhibición competitiva de la unión al ligando AR y actividad antiproliferativa.
  • Un conjugado cíclico mostró una potente actividad antiproliferativa a través de un mecanismo no competitivo.

Conclusiones:

  • Los conjugados peptidomiméticos desarrollados representan una plataforma versátil para diseñar nuevos moduladores de AR.
  • Se identificaron moduladores de AR competitivos y no competitivos con potencial terapéutico.
  • Estos hallazgos ofrecen estrategias prometedoras para atacar el cáncer de próstata resistente a la terapia.